EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
1 Year Est. Return
+377.14%
AUM
$866M
AUM Growth
-$31.6M
(-3.5%)
Holding
394
Top Buys
| 1 | +$8.18M | |
| 2 | +$6.78M | |
| 3 | +$6.63M | |
| 4 |
MYR Group
MYRG
|
+$6.49M |
| 5 |
Dana Inc
DAN
|
+$6.19M |
Top Sells
| 1 | +$11.3M | |
| 2 | +$8.28M | |
| 3 | +$7.48M | |
| 4 |
Lumentum
LITE
|
+$7.28M |
| 5 |
Guardant Health
GH
|
+$7.26M |
Sector Composition
| 1 | Industrials | 23.17% |
| 2 | Technology | 23.07% |
| 3 | Healthcare | 17.28% |
| 4 | Energy | 12.86% |
| 5 | Consumer Discretionary | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Telos
TLS
$307M
| – | – |
-105,100
|
|
||
377
The Oncology Institute
TOI
$487M
| – | – |
-182,509
|
|
||
378
Trevi Therapeutics
TRVI
$1.89B
| – | – |
-541,242
|
|
||
379
Taysha Gene Therapies
TSHA
$1.58B
| – | – |
-823,758
|
|
||
380
Travere Therapeutics
TVTX
$4.26B
| – | – |
-109,404
|
|
||
381
Urban Outfitters
URBN
$6.1B
| – | – |
-52,441
|
|
||
382
UroGen Pharma
URGN
$1.31B
| – | – |
-160,412
|
|
||
383
US Gold Corp
USAU
$227M
| – | – |
-44,974
|
|
||
384
Universal Insurance Holdings
UVE
$1.04B
| – | – |
-132,567
|
|
||
|
VSXY
385
Victoria's Secret
VSXY
$5.93B
| – | – |
-93,058
|
|
||
|
VTYX
386
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-111,398
|
|
||
387
Wave Life Sciences
WVE
$1.1B
| – | – |
-248,815
|
|
||
388
WidePoint Corp
WYY
$108M
| – | – |
-98,066
|
|
||
389
Xeris Biopharma Holdings
XERS
$1.07B
| – | – |
-80,154
|
|
||
390
Xometry
XMTR
$4.24B
| – | – |
-92,853
|
|
||
391
Zumiez
ZUMZ
$300M
| – | – |
-41,866
|
|
||
392
Zurn Elkay Water Solutions
ZWS
$7.9B
| – | – |
-155,011
|
|
||
|
RAPP
393
Rapport Therapeutics
RAPP
$1.73B
| – | – |
-85,555
|
|
||
|
GRAL
394
GRAIL Inc
GRAL
$2.57B
| – | – |
-29,692
|
|